Jump to content

List of investigational sleep drugs

From Wikipedia, the free encyclopedia

This is a list of investigational sleep drugs, or drugs for the treatment of sleep disorders that are currently under development for clinical use but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses.

Insomnia

[edit]

GABAA receptor potentiators

[edit]

Orexin receptor antagonists

[edit]
  • Seltorexant (MIN-202, JNJ,42847922, JNJ-922) – selective OX2 receptor antagonist [4]
  • Vornorexant (ORN-0829, TS-142) – dual OX1 and OX2 receptor antagonist [5]

Melatonin receptor agonists

[edit]

Nociceptin receptor agonists

[edit]

Hypersomnia/narcolepsy

[edit]

Orexin receptor agonists

[edit]

Monoaminergics

[edit]

GHB receptor agonists

[edit]

H3 receptor inverse agonists

[edit]

GABAA receptor inhibitors

[edit]

See also

[edit]

References

[edit]
  1. ^ "ALKS 2680". AdisInsight. 7 June 2024. Retrieved 31 July 2024.
  2. ^ a b "Takeda". www.ox2rsparkleprogram.com. Retrieved 2019-11-15.
  3. ^ "E-2086". AdisInsight. 15 July 2024. Retrieved 31 July 2024.
  4. ^ Konofal, Eric (2024). "From past to future: 50 years of pharmacological interventions to treat narcolepsy". Pharmacology Biochemistry and Behavior. 241: 173804. doi:10.1016/j.pbb.2024.173804.